Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humacyte (HUMA) Other Accumulated Expenses (2024 - 2025)

Humacyte has reported Other Accumulated Expenses over the past 2 years, most recently at $61000.0 for Q2 2025.

  • Quarterly results put Other Accumulated Expenses at $61000.0 for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $61000.0 (changed N/A YoY), and the annual figure for FY2024 was $238000.0, changed.
  • Other Accumulated Expenses for Q2 2025 was $61000.0 at Humacyte, up from $60000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for HUMA hit a ceiling of $238000.0 in Q4 2024 and a floor of $60000.0 in Q1 2025.